These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6426045)

  • 1. Risk factors in the treatment of rheumatoid arthritis with parenteral gold.
    Husby G; Gran JT
    Scand J Rheumatol Suppl; 1983; 51():112-5. PubMed ID: 6426045
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA DR antigens and gold toxicity.
    Gran JT; Husby G; Thorsby E
    Ann Rheum Dis; 1983 Feb; 42(1):63-6. PubMed ID: 6402993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR antigens and gold-induced enterocolitis.
    Sukenik S; Gladman D; Fam AG
    J Rheumatol; 1984 Feb; 11(1):109-10. PubMed ID: 6422039
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
    N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Dahlqvist SR; Ström H; Bjelle A; Möller E
    Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HLA-Bw35 with mucocutaneous lesions in rheumatoid arthritis patients undergoing sodium aurothiomalate therapy.
    Nüsslein HG; Jahn H; Lösch G; Guggenmoos-Holzmann I; Leibold W; Kalden JR
    Arthritis Rheum; 1984 Jul; 27(7):833-6. PubMed ID: 6430303
    [No Abstract]   [Full Text] [Related]  

  • 8. Chrysiasis following gold therapy for rheumatoid arthritis: ultrastructural analysis with x-ray energy spectroscopy.
    Pelachyk JM; Bergfeld WF; McMahon JT
    J Cutan Pathol; 1984 Dec; 11(6):491-4. PubMed ID: 6440909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
    Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N
    Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
    [No Abstract]   [Full Text] [Related]  

  • 11. Gold treatment for rheumatoid arthritis: reassurance on proteinuria.
    Collins AJ
    Br Med J (Clin Res Ed); 1987 Sep; 295(6601):739-40. PubMed ID: 3119018
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
    Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
    J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
    Bliddal H; Eiberg B; Helin P; Svejgaard A
    Ann Rheum Dis; 1989 Jul; 48(7):539-41. PubMed ID: 2570550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold therapy in rheumatoid arthritis.
    Schorn D; Anderson IF
    S Afr Med J; 1975 Aug; 49(37):1505-6. PubMed ID: 125934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of rheumatoid arthritis with gold salts].
    Aranguena L; Hinojosa W; Chincaro C; Portugal J; Barrenechea O
    Rev Clin Esp; 1984 Jun 15-30; 173(5-6):305-8. PubMed ID: 6238373
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
    Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
    Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria in rheumatoid arthritis--drug-induced or amyloid?
    Bourke BE; Woodrow DF; Scott JT
    Ann Rheum Dis; 1981 Jun; 40(3):240-4. PubMed ID: 6787994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Eosinophilia during gold therapy.
    Jessop JD; Dippy J; Turnbull A; Bright M
    Rheumatol Rehabil; 1974 May; 13(2):75-80. PubMed ID: 4276506
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteinuria in gold-treated rheumatoid arthritis.
    Katz WA; Blodgett RC; Pietrusko RG
    Ann Intern Med; 1984 Aug; 101(2):176-9. PubMed ID: 6430141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis.
    Hakala M; van Assendelft AH; Ilonen J; Jalava S; Tiilikainen A
    Ann Rheum Dis; 1986 Mar; 45(3):177-82. PubMed ID: 3456743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.